Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
US10151755B2 · kind B2 · utility
5Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 1, 2016 |
| Grant date | Dec 11, 2018 |
| Priority date | — |
| Expiry date | Jun 24, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/8146
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to biomarker assays based on protein/peptide biomarkers which show a pronounced differential behaviour between healthy and cancerous sample proteomes e.g. by mass spectrometric measurement and/or antibody-based assays such as an Enzyme-Linked Immunosorbent Assay (ELISA) determination of the protein biomarkers in serum, plasma or blood itself.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.